Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)
A Multi-Center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease
Status: Enrolling
Updated:  9/19/2017
Pacific Private Clinic
mi
from 98109
Queensland,
Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)
A Multi-Center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease
Status: Enrolling
Updated: 9/19/2017
Pacific Private Clinic
mi
from 98109
Queensland,
Click here to add this to my saved trials
Anesthesia and Motor Evoked Potential (MEP) Recruitment
The Effect of Anesthesia on the Recruitment of Motor Evoked Potentials Using an Increased Number of Pulses
Status: Enrolling
Updated:  9/19/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Anesthesia and Motor Evoked Potential (MEP) Recruitment
The Effect of Anesthesia on the Recruitment of Motor Evoked Potentials Using an Increased Number of Pulses
Status: Enrolling
Updated: 9/19/2017
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)
The Impact of Liposomal Bupivicaine on Post-Operative Pain in Orthopaedic Trauma Surgery: A Double-Blind Prospective Randomized Control Trial
Status: Enrolling
Updated:  9/19/2017
Jamaica Hospital Medical Center
2410
mi
from 98109
Jamaica, NY
Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)
The Impact of Liposomal Bupivicaine on Post-Operative Pain in Orthopaedic Trauma Surgery: A Double-Blind Prospective Randomized Control Trial
Status: Enrolling
Updated: 9/19/2017
Jamaica Hospital Medical Center
2410
mi
from 98109
Jamaica, NY
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
City of Hope Comprehensive Cancer Center
960
mi
from 98109
Duarte, CA
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
City of Hope Comprehensive Cancer Center
960
mi
from 98109
Duarte, CA
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
University of Kansas Cancer Center and Medical Pavilion
1504
mi
from 98109
Westwood, KA
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
University of Kansas Cancer Center and Medical Pavilion
1504
mi
from 98109
Westwood, KA
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Duke Cancer Center
2341
mi
from 98109
Durham, NC
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Duke Cancer Center
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Ohio State University
2006
mi
from 98109
Columbus, OH
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Washington University School of Medicine
1718
mi
from 98109
Saint Louis, MO
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Washington University School of Medicine
1718
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Hackensack University Medical Center - John Theurer Cancer Center
2394
mi
from 98109
Hackensack, NJ
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Hackensack University Medical Center - John Theurer Cancer Center
2394
mi
from 98109
Hackensack, NJ
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Huntsman Cancer Center, University of Utah
702
mi
from 98109
Salt Lake City, UT
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Huntsman Cancer Center, University of Utah
702
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Centre Hospitalier Universitaire de Grenoble
5293
mi
from 98109
La Tronche,
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Centre Hospitalier Universitaire de Grenoble
5293
mi
from 98109
La Tronche,
Click here to add this to my saved trials
Tranexamic Acid Use in Acute Hip Fractures
The Use of Tranexamic Acid to Reduce the Need for Transfusion 1 Week Post-operatively for Hemiarthroplasty or Intramedullary Nailing Needed to Correct Acute Hip Fractures
Status: Enrolling
Updated:  9/20/2017
Carilion Roanoke Memorial Hospital
2244
mi
from 98109
Roanoke, VA
Tranexamic Acid Use in Acute Hip Fractures
The Use of Tranexamic Acid to Reduce the Need for Transfusion 1 Week Post-operatively for Hemiarthroplasty or Intramedullary Nailing Needed to Correct Acute Hip Fractures
Status: Enrolling
Updated: 9/20/2017
Carilion Roanoke Memorial Hospital
2244
mi
from 98109
Roanoke, VA
Click here to add this to my saved trials
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
Status: Enrolling
Updated:  9/22/2017
Arizona Arthritis & Rheumatology
1106
mi
from 98109
Phoenix, AZ
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
Status: Enrolling
Updated: 9/22/2017
Arizona Arthritis & Rheumatology
1106
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Ohio State University
2006
mi
from 98109
Columbus, OH
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Avera Hematology & Transplant Center
1264
mi
from 98109
Sioux Falls, SD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Avera Hematology & Transplant Center
1264
mi
from 98109
Sioux Falls, SD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Texas Transplant Institute
1780
mi
from 98109
San Antonio, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Texas Transplant Institute
1780
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
City of Hope National Medical Center
959
mi
from 98109
Duarte, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
City of Hope National Medical Center
959
mi
from 98109
Duarte, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of California, San Diego Medical Center
1049
mi
from 98109
La Jolla, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of California, San Diego Medical Center
1049
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Stanford Hospital and Clinics
705
mi
from 98109
Stanford, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Stanford Hospital and Clinics
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Colorado Blood Cancer Institute
1021
mi
from 98109
Denver, CO
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Colorado Blood Cancer Institute
1021
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Florida College of Medicine
2451
mi
from 98109
Gainesville, FL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Florida College of Medicine
2451
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
BMT Program at Northside Hospital
2174
mi
from 98109
Atlanta, GA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
BMT Program at Northside Hospital
2174
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Ann & Robert Lurie Children's Hospital of Chicago
1733
mi
from 98109
Chicago, IL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Ann & Robert Lurie Children's Hospital of Chicago
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Indiana BMT at Beech Grove
1872
mi
from 98109
Beech Grove, IN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Indiana BMT at Beech Grove
1872
mi
from 98109
Beech Grove, IN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Maryland Medical Systems
2327
mi
from 98109
Baltimore, MD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Maryland Medical Systems
2327
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
DFCI, Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
DFCI, Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Dana-Farber Cancer Institute/Brigham & Women's Hospital
2485
mi
from 98109
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Dana-Farber Cancer Institute/Brigham & Women's Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Michigan Medical Center
1922
mi
from 98109
Ann Arbor, MI
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Michigan Medical Center
1922
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Hackensack University Medical Center
2394
mi
from 98109
Hackensack, NJ
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Hackensack University Medical Center
2394
mi
from 98109
Hackensack, NJ
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Weill Cornell Medical College NY Presbyterian Hospital
2402
mi
from 98109
New York, NY
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Weill Cornell Medical College NY Presbyterian Hospital
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of North Carolina Hospital at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of North Carolina Hospital at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Pennsylvania Cancer Center
2371
mi
from 98109
Philadelphia, PA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Pennsylvania Cancer Center
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Baylor University Medical Center
1681
mi
from 98109
Dallas, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Baylor University Medical Center
1681
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Texas MD Anderson Cancer Research Center
1892
mi
from 98109
Houston, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Texas MD Anderson Cancer Research Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Virginia Commonwealth University
2352
mi
from 98109
Richmond, VA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Virginia Commonwealth University
2352
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials